SHG:688739 - Liaoning Chengda Biotechnology Co Ltd Liaoning Chengda Biotechnology
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance
Annual TTM
Cash Flow Income Statement Key Ratios Personalized

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2019 Q4 2020 Q1 2020 Q2 2020 Q3 2020 Q4 2021 Q2 2021 Q3 Graph
Total Assets 3.74B
-
4.06B
8.6%
4.05B
-0.1%
4.4B
8.5%
4.48B
1.8%
5.15B
14.9%
5.36B
4.2%
Current Assets 2.49B
-
- 2.73B
-
- 3.05B
-
3.53B
15.9%
3.65B
3.3%
Cash Equivalents 1.33B
-
- 1.39B
-
- 1.49B
-
1.8B
21.0%
1.74B
-3.1%
NonCurrent Assets 1.24B
-
4.06B
226.8%
1.32B
-67.4%
4.4B
232.2%
1.43B
-67.5%
1.61B
12.9%
1.72B
6.3%
Total Liabilities 310.75M
-
326.56M
5.1%
331.16M
1.4%
367.85M
11.1%
360.17M
-2.1%
453.9M
26.0%
417.72M
-8.0%
Current Liabilities 177.55M
-
- 194.56M
-
- 228.87M
-
302.41M
32.1%
272.23M
-10.0%
NonCurrent Liabilities 133.2M
-
326.56M
145.2%
136.6M
-58.2%
367.85M
169.3%
131.31M
-64.3%
151.48M
15.4%
145.48M
-4.0%
Total Equity 3.42B
-
3.73B
8.9%
3.72B
-0.2%
4.03B
8.3%
4.12B
2.2%
4.69B
14.0%
4.95B
5.4%
Stockholders Equity 3.42B
-
3.73B
8.9%
3.72B
-0.2%
4.03B
8.3%
4.12B
2.2%
4.69B
14.0%
4.95B
5.4%
Minority Interest - - - - - - -
Values are in CNY whenever applicable | Fiscal year ends on December 31
Powered by Morningstar